Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2012
05/16/2012CN101490054B Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors
05/16/2012CN101466672B Salts of N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide
05/16/2012CN101434635B Water-soluble phenolic triterpenoid with antineoplastic activity and preparation thereof
05/16/2012CN101386594B 1,2,4,5-tetrahydro-3H-benzazepine derivatives, process for their preparation and pharmaceutical compositions containing them
05/16/2012CN101385741B Use of polysaccharide sulfate as anti influenza virus medicine
05/16/2012CN101376653B Flavonol compound, and preparation and use thereof
05/16/2012CN101370780B Organic compound of aripiprazole
05/16/2012CN101340905B Oral preparation for preventing or improving skin dryness
05/16/2012CN101282936B Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same
05/16/2012CN101253164B Indol-3-carbonyl-spiro-piperidine derivatives as v1a receptor antagonists
05/16/2012CN101247806B SnAr process for preparing benzimidazole compounds
05/16/2012CN101228127B Novel piperidine derivative
05/16/2012CN101171266B Acerola fruit-derived pectin and use thereof
05/16/2012CN101147725B Ketoconazole suppository composition for vaginal administration
05/16/2012CN101143853B Biphenyltetrazoles compounds and preparation method thereof
05/16/2012CN101137368B Roflumilast for the treatment of diabetes mellitus
05/16/2012CN101072566B Pharmaceutical compositions for transdermal delivery
05/16/2012CN101052360B Absorbable implants and methods for their use in hemostasis and in the treatment of osseous defects
05/16/2012CN101010075B Materials and methods for improving shellfish health, immunity and growth
05/15/2012USRE43390 Pleuromutilin derivatives as antimicrobials
05/15/2012US8178727 Bis(arylmethylidene)acetone compound, anti-cancer agent, carcinogenesis-preventive agent, inhibitor of expression of Ki-Ras, ErbB2, c-Myc and Cycline D1, β-catenin-degrading agent, and p53 expression enhancer
05/15/2012US8178724 Compounds for inhibition of 5-hydroxytryptamine and norepinephrine reuptake or for treatment of depression disorders, their preparation processes and uses thereof
05/15/2012US8178713 Sulfur-containing phospholipid derivatives
05/15/2012US8178712 Process for the synthesis of Ibandronate sodium
05/15/2012US8178709 Iron preparation suitable for pharmaceutical formulation and process for the preparation thereof
05/15/2012US8178708 Lipid derivatives
05/15/2012US8178694 Heterocyclylaminoalkyl substituted benzimidazoles
05/15/2012US8178693 N3 alkylated benzimidazole derivatives as MEK inhibitors
05/15/2012US8178690 Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
05/15/2012US8178689 Tricyclic compounds
05/15/2012US8178685 Pesticides
05/15/2012US8178684 Substituted nicotinamides as KCNQ2/3 modulators
05/15/2012US8178683 Antimicrobial ortho-fluorophenyl oxazolidinones for treatment of bacterial infections
05/15/2012US8178681 methyl 3-methyl-2-{[2-oxo-1-(2-oxo-ethyl)-1,2,5,6,7,8,9,10-octahydro-cycloocta[b]pyridine-3-carbonyl]-amino}-butyrate; cannabinoid receptor agonist; antiinflammatory agent, immunostimulant, analgesic; atopic dermatitis; excellent in photostability, and have excellent transdermal and oral absorbency
05/15/2012US8178677 Hydroxyalkyl substituted imidazoquinolines
05/15/2012US8178674 Process for the preparation of ziprasidone
05/15/2012US8178672 Synthesis of imidazooxazole and imidazothiazole inhibitors of p38 MAP kinase
05/15/2012US8178671 Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds
05/15/2012US8178663 Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring
05/15/2012US8178658 Pesticidal compositions
05/15/2012US8178584 Water-in oil emulsified composition
05/15/2012US8178583 Compounds
05/15/2012US8178582 Pharmaceutical compositions having desirable bioavailability
05/15/2012US8178580 Formulations and methods for treating amyloidosis
05/15/2012US8178579 Histone deacetylase inhibitors; anticancer agents; antiprotozoa agents
05/15/2012US8178578 Chemical compounds
05/15/2012US8178577 Tricyclic derivatives as potent and selective histone deacetylase inhibitors
05/15/2012US8178576 Non-polymeric lipophilic pharmaceutical implant compositions for intraocular use
05/15/2012US8178575 Derivatives of azabicyclo octane, the method of making them and the uses thereof as inhibitors of dipeptidyl peptidase IV
05/15/2012US8178574 Tosylate salt of trans-N-isobutyl-3-fluoro-3-[3-fluoro-4-(pyrrolidin-1-yl-methyl)-phenyl] cyclobut anecarboxamide
05/15/2012US8178573 Compounds
05/15/2012US8178572 Amino acid compounds
05/15/2012US8178571 Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same
05/15/2012US8178570 Tie-2 modulators and methods of use
05/15/2012US8178569 Crystalline imidazole-5-carboxylic acid derivative
05/15/2012US8178568 Sulfone compounds which modulate the CB2 receptor
05/15/2012US8178566 Crystal form of epothilone B and use in pharmaceutical compositions
05/15/2012US8178564 Use of picoplatin to treat colorectal cancer
05/15/2012US8178563 Compounds and compositions as hedgehog pathway modulators
05/15/2012US8178562 Pyridine derivatives
05/15/2012US8178561 Method for modulating GPR119 G protein-coupled receptor and selected compounds
05/15/2012US8178560 Therapeutic agents useful for treating pain
05/15/2012US8178559 Organic compounds
05/15/2012US8178558 Substituted pyridylmethyl bicycliccarboxyamide compounds
05/15/2012US8178557 Compounds and methods of use
05/15/2012US8178556 Pyridopyrazinones derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
05/15/2012US8178555 Apoptosis signal-regulating kinase 1 inhibitors
05/15/2012US8178554 Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents
05/15/2012US8178553 Compounds for the treatment of inflammatory disorders
05/15/2012US8178552 7-Azaindole derivatives and their use in the inhibition of c-Jun N-terminal kinase
05/15/2012US8178551 Orally bioavailable prodrugs of (+)-3-hydroxymorphinan for Parkinson'S disease prevention or treatment
05/15/2012US8178550 Hydrochloride salts of 8-[{1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxy)-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and preparation process therefor
05/15/2012US8178549 Azabicyclo [3. 1. O] hexyl derivatives as modulators of dopamine D3 receptors
05/15/2012US8178548 Anti-infective agents and uses thereof
05/15/2012US8178545 Dual small molecule inhibitors of cancer and angiogenesis
05/15/2012US8178544 2, 3-diamino-quinazolinone derivatives and their medical use
05/15/2012US8178543 Bi- and tricyclic fused pyrimidines as tyrosine kinase inhibitors
05/15/2012US8178542 Methods and compositions for treating pain
05/15/2012US8178541 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
05/15/2012US8178539 Substituted 3,4,6,7-tetrahydro-5H-1,2a,4a,8-tetraazacyclopenta[cd]phenalenes and methods
05/15/2012US8178538 Pyridazinones
05/15/2012US8178537 Solid state forms of varenicline salts and processes for preparation thereof
05/15/2012US8178536 Sirtuin modulating compounds
05/15/2012US8178535 Substituted sulfonamide compounds having bradykinin 1 receptor activity and use thereof as medicaments
05/15/2012US8178534 cMET inhibitors
05/15/2012US8178533 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
05/15/2012US8178532 c-Met modulators and method of use
05/15/2012US8178531 Antiviral agents
05/15/2012US8178530 Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases
05/15/2012US8178529 Imidazole substituted pyrimidines
05/15/2012US8178528 Histamine H3 receptor agents, preparation and therapeutic uses
05/15/2012US8178527 Tetra-substituted NDGA derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use
05/15/2012US8178526 Compounds and compositions as ITPKb inhibitors
05/15/2012US8178525 FXA inhibitors with cyclic amidoxime or cyclic amidrazone as P4 subunit, processes for their preparations, and pharmaceutical compositions and derivatives thereof
05/15/2012US8178524 Noribogaine in the treatment of pain and drug addiction
05/15/2012US8178523 Compounds for the treatment of hepatitis C
05/15/2012US8178522 Thiazoles
05/15/2012US8178521 Cefazolin sodium pentahydrate crystal and its molecular assembly preparation method
05/15/2012US8178520 Macrocyclic compounds as antiviral agents
05/15/2012US8178519 Antiinflammatory agents; heating glucocorticoid with water and surfactant
1 ... 1232 1233 1234 1235 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 ... 7860